[CG] Unexplained Raised Maternal Serum Alpha-Fetoprotein
exp date isn't null, but text field is
The association between unexplained MSAFP (1% overall obstetric population) and adverse antenatal outcomes has been recognised for several years. Specifically, an increased risk of fetal death, fetal growth restriction, preterm birth and pre-eclampsia have been described.
The higher the level of MSAFP the greater the risk of an adverse outcome. Once the MSAFP is >4 MOM there is a 41% fetal loss rate and a 60% rate of preterm delivery among the survivors.
If the human chorionic gonadotrophin (HCG) is also elevated the risk is further increased.
Management of women with an increased MSAFP (>2 MOM):
- Offer detailed anomaly scan.
- Offer scans in third trimester to assess growth and fetal wellbeing (see algorithm).
- Women should be reviewed after each scan at a consultant clinic.
- Deliver by EDD